Named Bioactive Compounds · Compound
Beta-Carotene (Carotenoid)
Strong Evidencecarotenoid5 PubMed Studies
Hermetica Superfood Encyclopedia
Beta-carotene is a provitamin A carotenoid that converts to retinol in the body and serves as a powerful antioxidant. It neutralizes free radicals through electron donation and supports vitamin A synthesis via intestinal enzyme cleavage.
Beta-carotene is a naturally occurring carotenoid pigment classified as a tetraterpenoid hydrocarbon, primarily sourced from plants such as carrots (Daucus carota), sweet potatoes (Ipomoea batatas), and dark leafy greens like spinach. Commercial extraction typically involves solvent extraction using hexane from plant sources or algal cultures (particularly Dunaliella salina), followed by purification via chromatography or crystallization for supplement production.
A 2022 meta-analysis of 31 RCTs involving 216,734 participants found no effect of beta-carotene supplementation on all-cause mortality (RR=1.02, 95% CI 0.98-1.05). The CARET trial (n=18,314) was stopped early due to 28% higher lung cancer incidence and 17% higher mortality in smokers receiving 30mg/day beta-carotene. A 2011 meta-analysis of 6 RCTs (n=40,544) confirmed no preventive benefit for cancer incidence or mortality.
Clinically studied doses range from 15-50 mg/day of synthetic or extracted beta-carotene, typically as powder or oil-based supplements. Common trial dosages include: ATBC/CARET studies used 20-30 mg/day, head/neck cancer trials used 50 mg/day, and AREDS used 15 mg/day as part of an antioxidant mix. Consult a healthcare provider before starting any new supplement.
Beta-Carotene is a fat-soluble carotenoid pigment (C40H56) with a molecular weight of 536.87 g/mol. It is not a macronutrient source and contributes negligible calories when consumed as an isolated compound. As a provitamin A carotenoid, it serves as the most efficient dietary precursor to retinol (vitamin A), with a conversion ratio of approximately 12:1 (12 µg dietary beta-carotene = 1 µg retinol activity equivalent/RAE) from food sources, and 2:1 from supplemental forms. Typical supplemental doses range from 1.5 mg to 50 mg/day (commonly 15–25 mg in clinical trials). Dietary intake from food averages 1.5–3 mg/day in Western populations, rising to 6–9 mg/day in high-vegetable-consuming populations. Bioavailability is highly variable: absorption ranges from 5–65% depending on food matrix, fat co-ingestion (requires dietary fat for micellar incorporation), cooking method (heat and mechanical disruption enhance release), and individual genetic variation in BCMO1 enzyme activity (SNPs in BCMO1 gene can reduce conversion efficiency by up to 57%). Bioavailability from supplements is significantly higher than from whole foods. Beta-carotene functions as a lipophilic antioxidant in vitro, capable of quenching singlet oxygen and scavenging peroxyl radicals, though in vivo antioxidant efficacy at supraphysiological supplemental doses is not consistently demonstrated and may paradoxically promote pro-oxidant activity in high-oxidative-stress environments (e.g., smokers' lung tissue). It contains no protein, fiber, or minerals. Stored predominantly in adipose tissue, liver, and skin; plasma concentrations typically range from 0.19–1.58 µmol/L in healthy adults, rising to 2–10 µmol/L with supplementation.
Beta-carotene functions as a provitamin A carotenoid, undergoing cleavage by β-carotene 15,15'-dioxygenase (BCO1) in intestinal cells to produce retinal, which converts to retinol. As an antioxidant, beta-carotene quenches singlet oxygen and neutralizes peroxyl radicals through electron transfer. It also modulates gene expression by activating retinoic acid receptors (RARs) after conversion to retinoic acid.
Large-scale randomized controlled trials have failed to demonstrate cancer prevention benefits, with meta-analyses of 40,544 participants showing no reduction in cancer incidence (RR=1.08). Cardiovascular disease protection studies involving 216,734 participants across 31 RCTs found no significant effects on CVD outcomes. Some studies suggest potential benefits for immune function and skin health, but evidence remains limited. High-dose supplementation (20-30mg daily) may actually increase lung cancer risk in smokers.
Beta-carotene supplementation is generally safe at doses under 15mg daily, though high doses can cause carotenemia (orange skin discoloration). Smokers should avoid high-dose supplements (≥20mg) due to increased lung cancer risk observed in clinical trials. Beta-carotene may interact with cholesterol-lowering drugs like cholestyramine, reducing absorption. It enhances fat-soluble vitamin absorption and may increase bleeding risk when combined with anticoagulant medications.
